Correspondence
Type III procollagen amino terminal propeptide: what does it measure in children?
First published: 12 May 2012
No abstract is available for this article.
References
- 1
Sugimoto M,
Masutani S,
Seki M
et al.
High serum levels of procollagen type III N-terminal amino peptide in patients with congenital heart disease.
Heart
2009; 95: 2023–8.
- 2
Trivedi P,
Cheeseman P,
Portmann B
et al.
Variation in serum type III procollagen peptide with age in healthy subjects and its comparative value in the assessment of disease activity in children and adults with chronic active hepatitis.
Eur J Clin Invest
1985; 15: 69–74.
- 3
Hørslev-Petersen K,
Bentsen KD,
Engström-Laurent A
et al.
Serum amino terminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: relation to clinical and serological parameters of inflammation during 8 and 24 months’ treatment with levamisole, penicillamine, or azathioprine.
Ann Rheum Dis
1988; 47: 116–26.
- 4
Guha N,
Erotokritou-Mulligan I,
Burford C
et al.
Serum insulin-like growth factor-I and pro-collagen type III N-terminal peptide in adolescent elite athletes: implications for the detection of growth hormone abuse in sport.
J Clin Endocrinol Metab
2010; 95: 2969–76.
- 5
Crofton PM,
Wade JC,
Taylor MRH,
Holland CV.
Serum concentration of carboxyl-terminal propeptide of type I procollagen, amino-terminal propeptide of type III procollagen, cross-linked carboxyl-terminal telopeptide of type I collagen, and their interrelationships in schoolchildren.
Clin Chem
1997; 43: 1577–81.
- 6
Erotokritou-Mulligan I,
Bassett EE,
Cowan DA
et al.
Influence of ethnicity on IGF-I and procollagen III peptide (P-III-P) in elite athletes and its effect on the ability to detect GH abuse.
Clin Endocrinol
2009; 70: 161–8.
- 7
Barker J,
Horn EJ,
Lebwohl M
et al.
Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic.
J Eur Acad Dermatol Venereol
2011; 25: 758–64.
